Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation.

The multidrug resistance p-glycoprotein (P-gp), encoded by the ABCB1 gene, is a plasma membrane protein that actively extrudes a wide variety of substances from cells. Preliminary studies in mice have shown that the ABCB1/P-gp can protect the fetus from a number of toxic substances. ABCB1/P-gp is expressed in the human placenta and is potentially capable of protecting the fetus from a large number of drugs and toxins, including herbicides and pesticides. The protein can also extrude various steroids including certain glucocorticoids and may therefore play an important role in regulating fetal access of glucocorticoids. The aim of the present study was to examine the expression profile and cellular localization of ABCB1/P-gp in human placenta throughout gestation. We hypothesized that there would be gestational age-related changes in the expression of the protein. ABCB1/P-gp mRNA was measured by Real-Time PCR using specific probes in tissues obtained from 6 weeks gestation to term. ABCB1/P-gp mRNA levels in placental tissue obtained at 6-10 weeks (n=5) and 24-35 weeks (n=5) were significantly higher than in tissues obtained at term (38-41 weeks gestation) by elective C-section (n=6) or following labor (n=6). The profile of ABCB1/P-gp protein levels, quantified using Western analysis, demonstrated a similar decrease with advancing gestation. At all gestational ages ABCB1/P-gp was localized by immunohistochemistry to the syncytiotrophoblast. In term tissues, it appeared to be localized to some areas of the villi and not others. Together, these data indicate that with advancing gestation there is a decrease in the level of ABCB1/P-gp in the human placenta indicating that the fetus may be more susceptible to toxic insults in the latter part of gestation. Further, the reduction in ABCB1/P-gp expression may contribute to the increased transfer of maternal cortisol to the fetus that is known to occur in late gestation.

[1]  M Grundmann,et al.  Influence of P-glycoprotein on the transplacental passage of cyclosporine. , 2001, Journal of pharmaceutical sciences.

[2]  M. Piquette-Miller,et al.  Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin , 2003, British journal of pharmacology.

[3]  N. Alfaidy,et al.  Expression of membrane prostaglandin E synthase in human placenta and fetal membranes and effect of labor , 2003, Endocrine.

[4]  P J Lucassen,et al.  Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. , 2001, Endocrinology.

[5]  J. H. Beijnen,et al.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.

[6]  J. Kigawa,et al.  Haplotype-Oriented Genetic Analysis and Functional Assessment of Promoter Variants in the MDR1 (ABCB1) Gene , 2004, Journal of Pharmacology and Experimental Therapeutics.

[7]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[8]  P. Kaufmann,et al.  Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1). , 2004, Pharmacogenetics.

[9]  P. Borst,et al.  Multidrug resistance and the role of P-glycoprotein knockout mice. , 1995, European journal of cancer.

[10]  P. Gros,et al.  Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities , 1990, Molecular and cellular biology.

[11]  S. Matthews.  Antenatal glucocorticoids and the developing brain: mechanisms of action. , 2001, Seminars in neonatology : SN.

[12]  A. Schinkel,et al.  P-Glycoprotein, a gatekeeper in the blood-brain barrier. , 1999, Advanced drug delivery reviews.

[13]  S. Horwitz,et al.  Transcriptional regulation of the murine multidrug resistance gene mdr1b by progesterone occurs via an indirect mechanism. , 1997, DNA and cell biology.

[14]  Peter W. Swaan,et al.  Structural Determinants of P-Glycoprotein-Mediated Transport of Glucocorticoids , 2003, Pharmaceutical Research.

[15]  G R Lankas,et al.  Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. , 1998, Reproductive toxicology.

[16]  R. Benediktsson,et al.  Placental 11β‐hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure , 1997 .

[17]  M. Sukhai,et al.  Decreased expression of P-glycoprotein in interleukin-1β and interleukin-6 treated rat hepatocytes , 2001, Inflammation Research.

[18]  R L Juliano,et al.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.

[19]  O. Meijer,et al.  Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. , 1998, Endocrinology.

[20]  J. Kigawa,et al.  Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. , 2001, The Journal of pharmacology and experimental therapeutics.

[21]  M. Mitchell,et al.  Inflammatory Cytokine mRNA in Human Gestational Tissues: Implications for Term and Preterm Labor , 1996, The Journal of the Society for Gynecologic Investigation: JSGI.

[22]  S. Khoo,et al.  The effects of protease inhibitors and nonnucleoside reverse transcriptase inhibitors on p-glycoprotein expression in peripheral blood mononuclear cells in vitro. , 2003, Journal of acquired immune deficiency syndromes.

[23]  D. Peer,et al.  Fluoxetine Inhibits Multidrug Resistance Extrusion Pumps and Enhances Responses to Chemotherapy in Syngeneic and in Human Xenograft Mouse Tumor Models , 2004, Cancer Research.

[24]  R Hori,et al.  Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. , 1992, The Journal of biological chemistry.

[25]  J. Hoyland,et al.  Sites of mRNA expression of the cystic fibrosis (CF) and multidrug resistance (MDR1) genes in the human placenta of early pregnancy: No evidence for complementary expression. , 1999, Placenta.

[26]  M. Mitchell,et al.  Cytokines of the placenta and extra-placental membranes: roles and regulation during human pregnancy and parturition. , 2002, Placenta.

[27]  J. Glazier,et al.  Expression of the cystic fibrosis (CF) and multidrug resistance (MDR1) genes during development and differentiation in the human placenta. , 1996, Molecular human reproduction.

[28]  M. Mitchell,et al.  Cytokines, prostaglandins and parturition--a review. , 2003, Placenta.

[29]  K. Kwek,et al.  Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. , 2002, The Journal of clinical endocrinology and metabolism.

[30]  W. Gibb,et al.  Localization of prostaglandin H synthase type 2 protein and mRNA in term human fetal membranes and decidua. , 1996, The Journal of endocrinology.

[31]  K. Audus,et al.  Functional expression of P-glycoprotein in primary cultures of human cytotrophoblasts and BeWo cells. , 2000, Reproductive toxicology.

[32]  C. Sibley,et al.  Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer. , 2003, American journal of physiology. Cell physiology.

[33]  W. Stein,et al.  Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. , 1997, Physiological reviews.

[34]  D. Housman,et al.  Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus , 1990, Molecular reproduction and development.

[35]  P. Borst,et al.  Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Lye,et al.  Endocrine and paracrine regulation of birth at term and preterm. , 2000, Endocrine reviews.

[37]  C. K. Pearson,et al.  Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta , 1994, The Histochemical Journal.